Company / Operating Cash Flow per Share
Johnson & Johnson Operating Cash Flow per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow per Share
$9.58
FY2025
5-year range
$7.94 / $9.58
FY2021-FY2025
Trend
+5.2%
vs FY2024
Sector context
#11 of 212
Health Care
What the data says
Among 212 Health Care companies, Johnson & Johnson is in the top 5% for operating cash flow per share. Operating Cash Flow per Share has increased for 3 consecutive years, from $7.94 in FY2022 to $9.58 in FY2025.
Based on SEC 10-K filings.
9.58 in FY2025 with a 5-year CAGR of +2.1%. Top quartile in the Health Care sector.
Improved from $8.52 to $9.58 over the past 2 years.
Health Care sector context is included.
Operating Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- +6.5%
- 5-Year CAGR
- +2.1%
- 10-Year CAGR
- -
Sector benchmark
+165.2% above sector average
Key checks
Key Insights
- Johnson & Johnson's operating cash flow per share has grown for 3 consecutive years.
- In FY2025, operating cash flow per share increased 5.2% year-over-year.
- Ranks #11 out of 212 companies in the Health Care sector.
- Lowest operating cash flow per share in the period was in FY2016.
Company context
Key Data Points
- Strong profit margin: 27.3%
- Strong return on equity: 31.7%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $9.58 | +5.2% |
| FY2024 | $9.11 | +6.9% |
| FY2023 | $8.52 | +7.4% |
| FY2022 | $7.94 | -9.0% |
| FY2021 | $8.72 | +1.1% |
| FY2020 | $8.63 | +1.1% |
| FY2019 | $8.53 | +7.1% |
| FY2018 | $7.96 | +6.3% |
| FY2017 | $7.49 | +14.2% |
| FY2016 | $6.55 | -3.7% |
As of FY2025 · SEC 10-K · Updated Mar 11, 2026